Innate lymphoid cells and the MHC

HLA

Volumn 87, Issue 1, 2016, Pages 5-11

  Robinette, M L ^a   Colonna, M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Human; Human leukocyte antigen; Innate; Innate lymphoid cells; MHC; Mouse

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CYTOKINE; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CELL SUBPOPULATION; HUMAN; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; REVIEW; SPECIES DIFFERENCE; T LYMPHOCYTE; ANIMAL; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENETICS; HELPER CELL; IMMUNOLOGY; INNATE IMMUNITY; MOUSE;

ANIMALS; ANTIGENS, CD; CYTOKINES; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; RECEPTORS, NK CELL LECTIN-LIKE; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84983539688     PISSN: 20592302     EISSN: 20592310     Source Type: Journal    
DOI: 10.1111/tan.12723     Document Type: Review

References (75)

1. Spits H, Artis D, Colonna M et al. Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol 2013: 13: 145-9.
2. Diefenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014: 41: 354-65.
3. McKenzie AN, Spits H, Eberl G. Innate lymphoid cells in inflammation and immunity. Immunity 2014: 41: 366-74.
4. Eberl G, Colonna M, Di Santo JP, McKenzie AN. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science 2015: 348: aaa6566.
5. Artis D, Spits H. The biology of innate lymphoid cells. Nature 2015: 517: 293-301.
6. Sonnenberg GF, Artis D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 2015: 21: 698-708.
7. Cella M, Miller H, Song C. Beyond NK cells: the expanding universe of innate lymphoid cells. Front Immunol 2014: 5: 282.
8. Cortez VS, Robinette ML, Colonna M. Innate lymphoid cells: new insights into function and development. Curr Opin Immunol 2015: 32: 71-7.
9. Vermijlen D, Prinz I. Ontogeny of innate T lymphocytes - some innate lymphocytes are more innate than others. Front Immunol 2014: 5: 486.
10. Robinette ML, Fuchs A, Cortez VS et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol 2015: 16: 306-17.
11. Lanier LL. NK cell recognition. Annu Rev Immunol 2005: 23: 225-74.
12. Caligiuri MA. Human natural killer cells. Blood 2008: 112: 461-9.
13. Yokoyama WM. Natural killer cell immune responses. Immunol Res 2005: 32: 317-25.
14. Mebius RE, Rennert P, Weissman IL. Developing lymph nodes collect CD4 + CD3- LTbeta + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997: 7: 493-504.
15. Adachi S, Yoshida H, Kataoka H, Nishikawa S. Three distinctive steps in Peyer's patch formation of murine embryo. Int Immunol 1997: 9: 507-14.
16. van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol 2010: 10: 664-74.
17. Crellin NK, Trifari S, Kaplan CD, Cupedo T, Spits H. Human NKp44 + IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med 2010: 207: 281-90.
18. Cella M, Fuchs A, Vermi W et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009: 457: 722-5.
19. Vonarbourg C, Mortha A, Bui VL et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 2010: 33: 736-51.
20. Klose CS, Flach M, Mohle L et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014: 157: 340-56.
21. Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat Rev Immunol 2011: 11: 645-57.
22. Oliphant CJ, Hwang YY, Walker JA et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014: 41: 283-95.
23. Goto Y, Panea C, Nakato G et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 2014: 40: 594-607.
24. Hepworth MR, Monticelli LA, Fung TC et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 2013: 498: 113-7.
25. Hepworth MR, Fung TC, Masur SH et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science 2015: 348: 1031-5.
26. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975: 16: 216-29.
27. Kiessling R, Klein E, Pross H, Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975: 5: 117-21.
28. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med 1971: 134: 1513-28.
29. Lanier LL, Phillips JH, Hackett J Jr, Tutt M, Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol 1986: 137: 2735-9.
30. Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989: 169: 2233-8.
31. Walzer T, Blery M, Chaix J et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA 2007: 104: 3384-9.
32. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986: 319: 675-8.
33. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990: 11: 237-44.
34. Hoglund P, Ohlen C, Carbone E et al. Recognition of beta 2-microglobulin-negative (beta 2 m-) T-cell blasts by natural killer cells from normal but not from beta 2 m- mice: nonresponsiveness controlled by beta 2 m- bone marrow in chimeric mice. Proc Natl Acad Sci USA 1991: 88: 10332-6.
35. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991: 349: 329-31.
36. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992: 358: 66-70.
37. Moretta A, Vitale M, Bottino C et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993: 178: 597-604.
38. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993: 260: 1121-4.
39. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995: 2: 439-49.
40. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998: 391: 795-9.
41. Lee N, Llano M, Carretero M et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998: 95: 5199-204.
42. Salcedo M, Bousso P, Ljunggren HG, Kourilsky P, Abastado JP. The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur J Immunol 1998: 28: 4356-61.
43. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 1998: 188: 1841-8.
44. Burshtyn DN, Scharenberg AM, Wagtmann N et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996: 4: 77-85.
45. Campbell KS, Dessing M, Lopez-Botet M, Cella M, Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 1996: 184: 93-100.
46. Lanier LL. Natural killer cell receptor signaling. Curr Opin Immunol 2003: 15: 308-14.
47. Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol 2008: 8: 713-25.
48. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013: 31: 227-58.
49. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002: 296: 1323-6.
50. Smith HR, Heusel JW, Mehta IK et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002: 99: 8826-31.
51. El-Gazzar A, Groh V, Spies T. Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer. J Immunol 2013: 191: 1509-15.
52. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 2013: 31: 413-41.
53. Cohen GB, Gandhi RT, Davis DM et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999: 10: 661-71.
54. Petersen JL, Morris CR, Solheim JC. Virus evasion of MHC class I molecule presentation. J Immunol 2003: 171: 4473-8.
55. Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 2003: 195: 346-55.
56. Triebel F, Jitsukawa S, Baixeras E et al. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 1990: 171: 1393-405.
57. Baixeras E, Huard B, Miossec C et al. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med 1992: 176: 327-37.
58. Holling TM, Schooten E, van Den Elsen PJ. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum Immunol 2004: 65: 282-90.
59. Kambayashi T, Laufer TM. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat Rev Immunol 2014: 14: 719-30.
60. Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol 2015: 15: 203-16.
61. Schooten E, Klous P, van den Elsen PJ, Holling TM. Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region. Immunogenetics 2005: 57: 795-9.
62. Roncarolo MG, Bigler M, Haanen JB et al. Natural killer cell clones can efficiently process and present protein antigens. J Immunol 1991: 147: 781-7.
63. Kim MY, Rossi S, Withers D et al. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 2008: 124: 166-74.
64. Takatori H, Kanno Y, Watford WT et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009: 206: 35-41.
65. Magri G, Cerutti A. Role of group 3 innate lymphoid cells in antibody production. Curr Opin Immunol 2015: 33: 36-42.
66. Kim HY, Lee HJ, Chang YJ et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 2014: 20: 54-61.
67. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A. A committed precursor to innate lymphoid cells. Nature 2014: 508: 397-401.
68. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 2010: 107: 10961-6.
69. Klose CS, Kiss EA, Schwierzeck V et al. A T-bet gradient controls the fate and function of CCR6-RORgammat + innate lymphoid cells. Nature 2013: 494: 261-5.
70. Ivanov II, Atarashi K, Manel N et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009: 139: 485-98.
71. Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med 2001: 194: 393-406.
72. Waldburger JM, Rossi S, Hollander GA, Rodewald HR, Reith W, Acha-Orbea H. Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells. Blood 2003: 101: 3550-9.
73. Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005: 5: 793-806.
74. Orange JS. Natural killer cell deficiency. J Allergy Clin Immunol 2013: 132: 515-25.
75. Pietra G, Vitale C, Pende D et al. Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias. Cancer Immunol Immunother 2015. DOI: 10.1007/s00262-015-1744-y. [Epub ahead of print].